70961008: Neomycin sulfate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin sulfate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin sulfate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Glycoside (substance)\Aminoglycoside (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin sulfate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Neomycin sulfate	Is a	Product containing neomycin (medicinal product)	false	Inferred relationship	Some
Neomycin sulfate	Is a	Baktericid	false	Inferred relationship	Some
Neomycin sulfate	Is a	Neomycin (substance)	false	Inferred relationship	Some
Neomycin sulfate	Is a	Substance with aminoglycoside structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Neomycin sulfate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Neomycin (substance)	true	Inferred relationship	Some
Neomycin sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Neomycin sulfate [systemic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 5 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
neomycinsulfat 0,5 % øjendråber til engangsbrug	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 5 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate [ear]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate [skin]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 25 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neo-tabs 500mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Mycifradin 125mg/5mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neo-fradin 125mg/5mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Chlorhexidine hydrochloride+neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
bacitracinzink 400 enheder + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
dexamethason 1 mg + neomycinsulfat 3,5 mg salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
gramicidin 0,025 mg + neomycinsulfat 1,75 mg + polymyxin B-sulfat 10.000 enheder opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/10.000 opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortison 10 mg + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/7,5 mg/10.000 enheder suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortison 10 mg + neomycinsulfat 7,5 mg + polymyxin B-sulfat 1.000 enheder opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortisonacetat 5 mg + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder creme	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
neomycinsulfat + polymyxin B-sulfat + prednisolonacetat 0,35 %/10.000 enheder/0,5 % wt/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
neomycinsulfat + polymyxin B-sulfat + prednisolonacetat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
gramicidin + neomycinsulfat + polymyxin B-sulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
colistinsulfat + hydrocortisonacetat + neomycinsulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
bacitracinzink + neomycinsulfat + polymyxin B-sulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortison + neomycinsulfat + polymyxin B-sulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
hydrocortisonacetat + neomycinsulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
dexamethason + neomycinsulfat + polymyxin B-sulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
dexamethasonnatriumphosphat +neomycinsulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
allergi over for neomycinsulfat	Causative agent	False	Neomycin sulfate	Inferred relationship	Some
bivirkning af chlorhexidinhydrochlorid + neomycinsulfat	Causative agent	False	Neomycin sulfate	Inferred relationship	Some	1
allergi over for chlorhexidinhydrochlorid og neomycinsulfat	Causative agent	False	Neomycin sulfate	Inferred relationship	Some
clobetasolpropionat + neomycinsulfat + nystatin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
clobetasonbutyrat + neomycinsulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
allergi over for neomycinsulfat	Causative agent	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 0.5% conventional release eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 500 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 25 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 25 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	2
Neomycin sulfate 5 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 5 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 0.5% conventional release eye drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 0.5% conventional release eye drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	2
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 5 mg/mL eye drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 5 mg/mL eye drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
neomycin + hydrocortison 0,5 %/1,5 % øjen-/øredråber	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
neomycin + hydrocortison 0,5 %/1,5 % øjen-/øredråber	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
allergi over for chlorhexidinhydrochlorid og neomycinsulfat	Causative agent	False	Neomycin sulfate	Inferred relationship	Some	1
Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	3

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
117867011	Neomycin sulfate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
501730016	Neomycin sulphate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
811074015	Neomycin sulfate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2796001000005112	Neomycinsulfat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)